Maen Hussein is an Oncology physician. OpenAlex indexes 94 publications with 5,587 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 N Us Highway 441 Ste 540
Lady Lake, FL 321598987
Telephone
352-753-9777Provider last certified this registry record 30 Jan 2026.
Industry payments
91 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20256 payments$19,618openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202511 payments
- PFIZER INC.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
55.1%PD-1 inhibitor24.5%Nivolumab54%Pembrolizumab46%Part B, office-administered≥24 patientsMicrotubule Inhibitor9.8%Paclitaxel78%Docetaxel22%Part B, office-administered≥18 patients+ 16 more classes in this area
Metabolism & gastrointestinal
15.3%Substance P/Neurokinin-1 Receptor Antagonist8.6%Aprepitant100%Part B, office-administered≥37 patientsOther antiemetics4.3%Fosaprepitant100%Part B, office-administered≥23 patients+ 6 more classes in this area
Blood & clotting
12.5%Parenteral Iron Replacement7.1%Iron sucrose100%Part B, office-administered≥29 patientsErythropoiesis-stimulating Agent3.8%Epoetin alfa100%Part B, office-administered≥41 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”